SuperworthMineralys Therapeutics shares outstanding MLYS
Diluted shares outstanding, averaged over each quarter, from 2022.
- Latest quarter, to Jun 30, 2026
- 84.7M
- On a year earlier
- +29.5%
- more shares
Mineralys Therapeutics had 84.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 29.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 81.1M | +62% |
| FY2024 | 50M | +25% |
| FY2023 | 40.1M | +669% |
| FY2022 | 5.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 84.7M | +29% | |
| Q1 FY26 | 82.8M | +56% | |
| Q4 FY25 | 81.1M | +62% | |
| Q3 FY25 | 70.6M | +42% | |
| Q2 FY25 | 65.5M | +33% | |
| Q1 FY25 | 53.2M | +18% | |
| Q4 FY24 | 50M | +25% | |
| Q3 FY24 | 49.8M | +25% | |
| Q2 FY24 | 49.4M | +24% | |
| Q1 FY24 | 44.9M | +81% | |
| Q4 FY23 | 40.1M | +669% | |
| Q3 FY23 | 39.9M | +671% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Mineralys Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.